Gilead Licenses Remdesivir To Five Firms
Cipla, Ferozsons, Hetero, Jubilant And Mylan Get Rights
Gilead has announced a raft of licensing agreements with five generics firms to manufacture potential COVID-19 treatment remdesivir for distribution in 127 countries.
